Dalian BIO-CHEM Balance Sheet Health
Financial Health criteria checks 5/6
Dalian BIO-CHEM has a total shareholder equity of CN¥1.7B and total debt of CN¥200.0M, which brings its debt-to-equity ratio to 11.5%. Its total assets and total liabilities are CN¥2.1B and CN¥353.0M respectively. Dalian BIO-CHEM's EBIT is CN¥394.5M making its interest coverage ratio -24.2. It has cash and short-term investments of CN¥579.7M.
Key information
11.5%
Debt to equity ratio
CN¥200.00m
Debt
| Interest coverage ratio | -24.2x |
| Cash | CN¥579.72m |
| Equity | CN¥1.74b |
| Total liabilities | CN¥352.98m |
| Total assets | CN¥2.09b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 603360's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥321.2M).
Long Term Liabilities: 603360's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥31.8M).
Debt to Equity History and Analysis
Debt Level: 603360 has more cash than its total debt.
Reducing Debt: 603360's debt to equity ratio has increased from 6% to 11.5% over the past 5 years.
Debt Coverage: 603360's debt is well covered by operating cash flow (111.3%).
Interest Coverage: 603360 earns more interest than it pays, so coverage of interest payments is not a concern.